{"id":41189,"date":"2023-11-20T00:47:06","date_gmt":"2023-11-20T06:47:06","guid":{"rendered":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/acrin-fmiso-brain-pub-1\/"},"modified":"2023-11-20T00:47:06","modified_gmt":"2023-11-20T06:47:06","slug":"acrin-fmiso-brain-pub-1","status":"publish","type":"tcia_citation","link":"https:\/\/stage.cancerimagingarchive.net\/tcia-citation\/acrin-fmiso-brain-pub-1\/","title":{"rendered":"ACRIN-FMISO-BRAIN-PUB-1"},"template":"","class_list":["post-41189","tcia_citation","type-tcia_citation","status-publish"],"tcia_citation_type":"Publication Citation","tcia_citation_text":"<p>Ratai, E.-M., Zhang, Z., Fink, J., Muzi, M., Hanna, L., Greco, E., Richards, T., Kim, D., Andronesi, O. C., Mintz, A., Kostakoglu, L., Prah, M., Ellingson, B., Schmainda, K., Sorensen, G., Barboriak, D., Mankoff, D., &amp; Gerstner, E. R. (2018). <strong>ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.<\/strong> In D. Monleon (Ed.), PLOS ONE (Vol. 13, Issue 6, p. e0198548). Public Library of Science (PLoS). <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6002091\/\">PMC6002091<\/a>. DOI:\u00a0 <a href=\"https:\/\/doi.org\/10.1371%2Fjournal.pone.0198548\">https:\/\/doi.org\/10.1371\/journal.pone.0198548<\/a>\u00a0<\/p>\n","tcia_citation_statement":"","tcia_citation_doi":"10.1371\/journal.pone.0198548","_links":{"self":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations\/41189","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/v1\/citations"}],"about":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/types\/tcia_citation"}],"wp:attachment":[{"href":"https:\/\/stage.cancerimagingarchive.net\/api\/wp\/v2\/media?parent=41189"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}